Multiple sclerosis and disease-modifying therapies

被引：4
|
作者：
Minen, Mia T.
Karceski, Steven
机构：
来源：
NEUROLOGY | 2011年 / 77卷 / 04期
关键词：
D O I：
10.1212/WNL.0b013e318229e6ca
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E26 / E26
页数：1
相关论文
共 50 条
  • [21] Assessing the risk of multiple sclerosis disease-modifying therapies
    Ayrignac, Xavier
    Bilodeau, Philippe-Antoine
    Prat, Alexandre
    Girard, Marc
    Labauge, Pierre
    Le Lorier, Jacques
    Larochelle, Catherine
    Duquette, Pierre
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (07) : 695 - 706
  • [22] Adherence to disease-modifying therapies in patients with multiple sclerosis
    Koltuniuk, Aleksandra
    Rosinczuk, Joanna
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 1557 - 1565
  • [23] Impact of Disease-Modifying Therapies on Fatigue in Multiple Sclerosis
    Voelter, H. U.
    Hildebrandt, H.
    Kastrup, A.
    AKTUELLE NEUROLOGIE, 2016, 43 (08) : 511 - 518
  • [24] The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis
    Benedikt Kretzschmar
    Hannah Pellkofer
    Martin S. Weber
    Current Neurology and Neuroscience Reports, 2016, 16
  • [25] Current and future disease-modifying therapies in multiple sclerosis
    Lim, S. Y.
    Constantinescu, C. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 637 - 650
  • [26] Disease-modifying therapies and infectious risks in multiple sclerosis
    Winkelmann, Alexander
    Loebermann, Micha
    Reisinger, Emil C.
    Hartung, Hans-Peter
    Zettl, Uwe K.
    NATURE REVIEWS NEUROLOGY, 2016, 12 (04) : 217 - 233
  • [27] Emerging disease-modifying oral therapies for multiple sclerosis
    Losy, Jacek
    Kalinowska-Lyszczarz, Alicja
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 231 (1-2) : 15 - 22
  • [28] Disease-modifying therapies and infectious risks in multiple sclerosis
    Alexander Winkelmann
    Micha Loebermann
    Emil C. Reisinger
    Hans-Peter Hartung
    Uwe K. Zettl
    Nature Reviews Neurology, 2016, 12 : 217 - 233
  • [29] Outpatient infections, multiple sclerosis and disease-modifying therapies
    Langer-Gould, A.
    Smith, J. B.
    Piehl, F.
    Li, B. H.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 635 - 636
  • [30] Disease-modifying therapies for multiple sclerosis: Focus on future direction
    Wilbanks, Jennifer
    FORMULARY, 2012, 47 (11) : 392 - 399
12345